Dergiler / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 2

Effect of Chronic Disease Mortality on COVID-19 Fatality Rate

Sayfa
117–122
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In regions with high average age and diabetes mortality, additional policies may be required to reduce the COVID-19 fatality rate.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: COVID-19 is a highly contagious disease that was caused by the coronavirus family SARS-CoV-2 and which emerged in China in 2019.
📊
Temel Bulgular & Veri:This study aimed to investigate the effect of chronic disease mortality on the COVID-19 fatality rate.
💡
Sonuç & Katkı:In regions with high average age and diabetes mortality, additional policies may be required to reduce the COVID-19 fatality rate.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: COVID-19 is a highly contagious disease that was caused by the coronavirus family SARS-CoV-2 and which emerged in China in 2019. This study aimed to investigate the effect of chronic disease mortality on the COVID-19 fatality rate. Methods: In our study, a total of 44 countries including 37 OECD countries were evaluated. A model was created with variables including death percentages of cardiovascular disease (CVD), cancer, chronic respiratory system diseases, diabetes and also age, gross domestic product (GDP), and the number of beds and the effect on COVID-19 fatality rate were evaluated. Multiple regression analysis was used to evaluate the model created. Results: It was determined that the average age and diabetes deaths among the non-communicable disease deaths positively predicted the COVID-19 fatality rate. In the model created in the study, the effect of the number of patient beds, GDP, and deaths due to CVD, cancer, and chronic respiratory diseases on the COVID-19 fatality rate was not determined. Discussion and Conclusion: In the study, older age and diabetes deaths positively predicted the COVID-19 fatality rate. In regions with high average age and diabetes mortality, additional policies may be required to reduce the COVID-19 fatality rate.

🔖

Bu Makaleye Atıf Yap

DAYAN, A., KUL, E. (2022). Effect of Chronic Disease Mortality on COVID-19 Fatality Rate. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 2, 117–122. https://ajindex.com/articles/535840

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43
  2. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet 2020;395:1014–5
  3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239–42
  4. Bassett BA. Strict lower bound on the COVID-19 fatality rate in overwhelmed healthcare systems. medRxiv 2020;1–4
  5. Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, et al. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin Infect Dis 2020;71:799– 806
  6. Li J, Wang X, Chen J, Zhang H, Deng A. Association of reninangiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol 2020;5:825–30
  7. European Centre for Disease Prevention and Control (2020). Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – tenth update. Available at: https://www.ecdc.europa.eu/en/ publicationsdata/rapid-risk-assessment-coronavirus-disease-2019-covid-19-pandemic-tenth-update#copy-to-clipboard. Accessed Feb 10, 2021
  8. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020;28:1195–9
  9. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Netw Open 2020;3:e205619
  10. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis. Int J Infect Dis 2016;49:129–33
  11. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259–60
  12. World Health Organization (2020). The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/ detail/the-top-10-causes-of-death. Accessed 5 Jan, 2021
  13. Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality From ischemic heart disease: Analysis of